• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Malignant Disease & Immunosuppression
Malignant Disease & Immunosuppression

Mycophenolate Mofetil Oral Suspension

Mycophenolate is an immunosuppressive agent.

Mycophenolate mofetil is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

Icon respresenting a network

Summary of Product Characteristics

More info
Icon respresenting a person

Patient Information Leaflet

More info
Malignant Disease & Immunosuppression

Mycophenolate Mofetil Oral Suspension

Flavour Raspberry
Storage Conditions Do not store above 25°C.
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 18 months / 60 days
PIP Code 1271402
EAN Code 05016119000942
PEG/NG Yes
Sodium Levels Essentially Sodium Free
Ethanol Concentration 50.00µg/5ml

Downloads

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch

[contact-form-7 id="275" title="Contact form 1" html_class="two-col-contact-form"]

Stay updated via our App

 

A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

Rosemont app on a mobile device

Malignant Disease & Immunosuppression

Mycophenolate Mofetil Oral Suspension